HVCN1 and cancer: To date, there are few specific inhibitors of the Hv1 proton channel, and much progress is required in the design and synthesis of drugs aimed at inhibiting the activity of this channel, however, this could have interesting results directed towards the strategy of growth control and development, focused on attacking the fine pH balance that characterize cancer cells.